# Task 144-10 - Package Readiness Schema Closure

## Status

Completed.

## Purpose

Task 144-10 documented the minimum safe package readiness schema for the Intake-to-Package MVP.

The schema defines how intake and evidence checklist results translate into non-investment readiness labels.

## Work Completed

Created:

- docs/intake_to_package_readiness_schema.md

The schema documentation covers:

- readiness object name
- required top-level fields
- readiness labels
- intake completeness input
- evidence checklist input
- blocker object
- warning object
- readiness rules for not_ready, partial, and ready_for_human_review
- human review requirement
- allowed next step values
- blocked next step values
- example readiness summaries
- acceptance criteria
- future implementation notes
- safety boundary

## Commit

- 958ad44 - Document intake to package readiness schema

## Verification

Latest verification before commit:

- python -m ruff check . passed.
- python -m pytest --basetemp=.pytest_tmp_current passed.
- Test count: 908 passed.
- git status clean after commit.

## Safety Boundaries Preserved

This task does not allow:

- actual persona reviews
- investor-agent execution
- investor decisions
- company recommendations
- company rankings
- allocations
- rebalancing
- trade signals
- execution instructions
- strategy validation
- auto-promotion

## Implementation Boundary

This task only added documentation.

It did not modify code, execute CLI commands, change CLI behavior, run investor agents, or generate investment outputs.

## Current MVP Documentation Stack

The Intake-to-Package MVP now has three core schema documents:

1. docs/intake_to_package_intake_schema.md
2. docs/intake_to_package_evidence_checklist_schema.md
3. docs/intake_to_package_readiness_schema.md

## Recommended Next Task

Task 144-11A should document the MVP implementation sequence before code begins.

Possible output:

- docs/intake_to_package_implementation_sequence.md

The sequence should define the safest order for future implementation: intake validation first, evidence checklist second, readiness classification third, reports fourth, and CLI only after safety review.
